# Lightermed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lightermed

- Industry: Healthcare IT
- Headquarters: Nanjing, China
- Website: www.lightermed.com/
- Latest round: Series A (Jul 17, 2025)
- Investors on record: 1

## About

Based in China, Lightermed is a clinical research and development company focused on accelerating drug and medical device development through innovative digital solutions and AI-driven technologies.Lightermed operates in the field of clinical research and development, founded in 2017 and headquartered in Nanjing, China. The company has successfully completed two deals, with its most recent deal dated July 17, 2025. The founder's details are not specified in the available information.Lightermed specializes in providing innovative clinical research and development services aimed at accelerating drug and medical device development. Their robust digital platform integrates online and offline resources to facilitate collaboration among healthcare professionals, researchers, and patients. Services offered include AI-driven research management tools, patient recruitment services, and comprehensive clinical monitoring solutions, catering to hospitals, pharmaceutical companies, and healthcare institutions across major markets, including China, the United States, and various European countries.Lightermed generates revenue through subscription-based access to its digital healthcare platform and partnerships with healthcare providers and research institutions. Their revenue model includes collaborative projects in clinical trial management and tailored solutions for drug development. Revenue is derived from agreements with healthcare organizations and pharmaceutical companies for services such as clinical monitoring, data management, and patient recruitment for clinical trials. Their offerings, including AI-enhanced research management services, are designed to meet the evolving needs of the healthcare sector.In July 2025, Lightermed raised an undisclosed amount in Series A+ funding from new investor Vangoo Capital Partners. The company plans to utilize this funding to expand its product offerings and enhance its digital platform. Future growth initiatives include the launch of new AI-driven tools aimed at improving clinical trial efficiency, with targeted releases expected in the upcoming year. Lightermed is also looking to expand into new geographic regions, including North America and Europe, by 2026, enhancing its service delivery to meet the needs of a broader client base.

## Funding rounds

- Series A, Jul 17, 2025 — Vangoo Capital Partners

## Investors

- Vangoo Capital Partners (https://capitalatlas.ai/funds/vangoo-capital-partners) — Series A